We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
39 hedge funds and large institutions have $89.8M invested in ESSA Pharma in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
5% more funds holding
Funds holding: 37 → 39 (+2)
0.36% more ownership
Funds ownership: 75.06% → 75.41% (+0.36%)
9% less capital invested
Capital invested by funds: $98.3M → $89.8M (-$8.5M)
10% less call options, than puts
Call options by funds: $96K | Put options by funds: $107K
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
Holders
39
Holders Change
+2
Holders Change %
+5.41%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
10
Closed
3
Calls
$96K
Puts
$107K
Net Calls
-$11K
Net Calls Change
-$83K
Top Buyers
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$810K |
| 2 |
ABG
Ally Bridge Group
New York
|
-$703K |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$693K |
| 4 |
Two Sigma Advisers
New York
|
-$415K |
| 5 |
CIBC World Market
Toronto,
Ontario, Canada
|
-$141K |
